BCL2 and adrenal cortex carcinoma: Specifically, in prostate cancer cells, laryngeal squamous cell carcinoma (LSCC), and adrenocortical carcinoma (ACC) SW-13 cells, miR-205 upregulation has been shown to significantly reduce both BCL-2 mRNA and protein expression levels.